InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Bushnell Laura I., Director. Officer active across 1 companies, notably Vincerx Pharma, Inc.. Aggregated, 5 reports have been published. Total volume traded: €111k. The latest transaction was filed on 9 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations5 total
€26,95515,000 shares@ €1.7970.28% mcap24.3% of flow
Common Stock
SEC:0000899243-22-022268:0·
Ideal exit: 6 Mar 2023 (T+270)
€22,3012,402 shares@ €9.28450.23% mcap53.2% of flow
Common Stock
SEC:0000899243-21-049775·
Ideal exit: 18 Sept 2022 (T+270)
€22,3012,402 shares@ €9.28450.23% mcap20.1% of flow
Common Stock
SEC:0000899243-21-049775:0·
Ideal exit: 18 Sept 2022 (T+270)
€19,6491,800 shares@ €10.91610.21% mcap46.8% of flow
Common Stock
SEC:0000899243-21-026819·
Ideal exit: 27 Mar 2022 (T+270)
€19,6491,800 shares@ €10.91610.21% mcap17.7% of flow
Common Stock
SEC:0000899243-21-026819:0·
Ideal exit: 27 Mar 2022 (T+270)
5 of 5 declarations
About Bushnell Laura I.
Laura I. Bushnell is a Board Member at Vincerx Pharma, Inc. She contributes to the governance of the company by bringing her expertise in biopharmaceuticals and strategy. Her role is essential in guiding the board's decisions.
